2013-02-14 20:02:42 - Recently published research from GlobalData, "Repligen Corporation (RGEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile", is now available at Fast Market Research

Repligen Corporation (Repligen) is a biopharmaceutical company indulged in discovery, development and commercialization of novel therapeutics in the areas of neurology and gastroenterology. The company also has a bio-processing business to develop and market products which are then used in production of biopharmaceuticals. The commercialized portfolio of the company includes a line of bio-processing products based on Protein A as well as a product line of pre-packed chromatography columns used for the purification of biopharmaceuticals and vaccines under the trade name Opus. The pipeline product portfolio of the Repligen includes RG 1068 or secretin (under the trade name SecreFlo) which is currently in Phase III clinical trial stage for the MRI imaging of pancreas and Phase-II clinical trial stage for

pancreatic cancer; RG2833 (Histone Deacetylase Inhibitors) which is pre-clinical stage being developed for the treatment of Friedreich’s Ataxia and memory discorders; and RG3039 (DcpS Inhibitors) which is inPhase I clinical trial stage for the treatment of spinal muscular atrophy. The drug candidate RG1068 has received a orphan drug and fast track drug designation from the US Food and Drug Administration (FDA). The company has a network of direct sales force and distribution partners for the marketing of its bio-processing products. Repligen is headquartered at Waltham in Massachusetts, the US.


Full Report Details at
- www.fastmr.com/prod/540552_repligen_corporation_rgen_pharmaceuti ..


The company focuses on successful development of its product pipeline as well as expanding its commercialized products range which is reflected from its recent filing of marketing authorization application in Europe for SecreFlo; new drug application for SecreFlo for MRI imaging in patients with pancreatitis; and introduction of Opus product line. The company also concentrates on increasing its coverage in newer markets geographically as indicated by its recent acquisition of Novozymes Biopharma Sweden AB.

Repligen Corporation (RGEN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals and Healthcare eTrack deals database, and primary and secondary research.

Scope

* Financial Deals - Analysis of the company's financial deals including M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
* Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
* Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as M&A, Equity/Debt Offering etc.
* Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
* Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
* Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
* Business Description - A brief description of the company's operations.
* Key Employees - A list of the key executives of the company.
* Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
* Key Competitors - A list of the key competitors of the company.
* Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

* The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

* The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

* Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

* The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

* Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

*

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.